{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:22:26Z","timestamp":1789611746355,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["77606011"],"award-info":[{"award-number":["77606011"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["2022\/2023 COVID-19"],"award-info":[{"award-number":["2022\/2023 COVID-19"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijregi.2025.100738","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T22:41:53Z","timestamp":1756593713000},"page":"100738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prevalence and characterization of post-acute sequelae of SARS-CoV-2 infection (PASC) in Rwanda"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-723X","authenticated-orcid":false,"given":"Fernand","family":"Rwamwejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne Umuhire","family":"Niyonkuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Rukundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Remera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Rwagasore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Les","family":"Sztandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ruranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-9700","authenticated-orcid":false,"given":"Elizabeth","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100738_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113426","article-title":"How and why patients made Long Covid","volume":"268","author":"Callard","year":"2021","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijregi.2025.100738_bib0002","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Geneva: World Health Organization, 2021."},{"key":"10.1016\/j.ijregi.2025.100738_bib0003","unstructured":"Worldometers. Worldometer population estimates from UN data, https:\/\/www.worldometers.info\/world-population\/africa-population; n.d. [accessed 18 February 2024]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0004","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100738_bib0005","article-title":"Global prevalence of long COVID, its subtypes and risk factors: an updated systematic review and meta-analysis","author":"Hou","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.ijregi.2025.100738_bib0006","unstructured":"NISR, National Institute of Statistics of Rwanda. Population size and Population characteristics. National Institute of Statistics of Rwanda, https:\/\/www.statistics.gov.rw\/statistical-publications\/population-size-and-population-characteristics; n.d. [accessed 28 June 2025]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijregi.2025.100738_bib0008","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12874-022-01694-7","article-title":"Sample size calculation for prevalence studies using Scalex and ScalaR calculators","volume":"22","author":"Naing","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijregi.2025.100738_bib0009","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2021."},{"key":"10.1016\/j.ijregi.2025.100738_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijregi.2023.08.004","article-title":"Burden, causation, and particularities of long COVID in African populations: a rapid systematic review","volume":"8","author":"Nyasulu","year":"2023","journal-title":"IJID Reg"},{"key":"10.1016\/j.ijregi.2025.100738_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1415427","article-title":"The prolonged health sequelae \u201cof the COVID-19 pandemic\u201d in sub-Saharan Africa: a systematic review and meta-analysis","volume":"13","author":"Alie","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijregi.2025.100738_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088983","article-title":"Post-COVID-19 conditions and health effects in Africa: a scoping review","volume":"15","author":"Ansah","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijregi.2025.100738_bib0013","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijregi.2025.100738_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ijregi.2025.100738_bib0015","unstructured":"GAVI. VaccinesWork. Nine Factors That Could Boost Your Risk of Long COVID, https:\/\/www.gavi.org\/vaccineswork\/nine-factors-could-boost-your-risk-long-covid; 2022 [accessed 28 June 2025]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.ijregi.2025.100738_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.38804","article-title":"Prevalence and correlates of long COVID symptoms among US adults","volume":"5","author":"Perlis","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijregi.2025.100738_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijregi.2025.100738_bib0019","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1038\/s41467-022-35240-2","article-title":"Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants","volume":"13","author":"Magnusson","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijregi.2025.100738_bib0020","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","article-title":"Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2","volume":"399","author":"Antonelli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2025.100738_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109536","article-title":"Long COVID across SARS-CoV-2 variants, lineages, and sublineages","volume":"27","author":"Padilla","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ijregi.2025.100738_bib0022","unstructured":"IGIHE. Covid-19 re-emerges in Rwanda, https:\/\/en.igihe.com\/health\/article\/covid-19-re-emerges-in-rwanda; 2025 [accessed 29 June 2025]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0023","unstructured":"World Health Organization. Risk evaluation for SARS-CoV-2 Variant under Monitoring: NB.1.8.1, https:\/\/www.who.int\/publications\/m\/item\/risk-evaluation-for-sars-cov-2-variant-under-monitoring-nb.1.8.1; 2025 [accessed 29 June 2025]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0024","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjmed.2024.02.032","article-title":"Factors associated with long COVID: insights from two nationwide surveys","volume":"137","author":"Wu","year":"2024","journal-title":"Am J Med"},{"key":"10.1016\/j.ijregi.2025.100738_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12939-023-02072-5","article-title":"An intersectional analysis of long COVID prevalence","volume":"22","author":"Cohen","year":"2023","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.ijregi.2025.100738_bib0026","unstructured":"World Health Organization. Health literacy, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/health-literacy; 2024 [accessed 29 June 2025]."},{"key":"10.1016\/j.ijregi.2025.100738_bib0027","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.vaccine.2022.05.090","article-title":"The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study","volume":"40","author":"Wynberg","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijregi.2025.100738_bib0028","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1007\/s10072-022-06138-0","article-title":"characteristics and risk factors in a Moroccan cohort of long-Covid-19","volume":"43","author":"El Otmani","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ijregi.2025.100738_bib0029","article-title":"Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data","volume":"30","author":"Bello-Chavolla","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.ijregi.2025.100738_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annepidem.2024.02.007","article-title":"The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022","volume":"92","author":"MacCallum-Bridges","year":"2024","journal-title":"Ann Epidemiol"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:13:53Z","timestamp":1778933633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S2772707625001730"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100738","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and characterization of post-acute sequelae of SARS-CoV-2 infection (PASC) in Rwanda","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100738"}}